A. Argiles et al., CALCIUM BALANCE AND INTACT PTH VARIATIONS DURING HEMODIAFILTRATION, Nephrology, dialysis, transplantation, 10(11), 1995, pp. 2083-2089
Background. Recent approaches to prevent and treat secondary hyperpara
thyroidism in dialysis patients include decreasing dialysate Ca conten
t from 1.75 to 1.5 mM or lower. We have recently observed that by decr
easing dialysate Ca to 1.25 mM a rise in intact parathormone serum lev
els occurs despite adequately controlled predialysis Ca and phosphate
serum levels. In that study complementary treatment with high-dose 1 a
lpha(OH) vitamin D3 was required to suppress the parathormone. In the
present study we aimed to assess the total Ca balance as well as the m
odifications in parathormone induced by the dialysis session in order
to understand the reasons for which the rise in parathormone was induc
ed. Methods. Fourteen HD patients treated with haemodiafiltration thre
e times/week gave their informed consent for the study. They were dist
ributed in two groups with identical treatment but for the dialysate C
a content which was 1.5 and 1.25 mM respectively and for the amount of
oral CaCO3 received. Total and ionized Ca, phosphate, pH, and albumin
as well as parathormone were measured in serum before and after dialy
sis and in the spent dialysate during two dialysis sessions. Results.
Serum ionized Ca (normalized to pH 7.4) did not change during 1.25 mM
dialysate Ca and significantly increased with 1.5 mM (P < 0.001). The
end-dialysis values being 1.25+/-0.02 and 1.38+/-0.02 mM respectively.
Total Ca significantly decreased with 1.25 mM dialysate Ca (P < 0.04)
and increased with 1.5 mM (P < 0.003), the end-dialysis values being
2.51+/-0.03 and 2.75+/-0.04 mM respectively. In the dialysate the diff
erence in ionized Ca concentrations, fresh minus spent dialysate was -
1.78+/-1.12 mmol/l (NS) and 4.26+/-1.47 mmol/l (P < 0.02) respectively
for 1.25 and 1.5 mM dialysate Ca. The difference in total Ca concentr
ations, fresh minus spent dialysate was -0.1+/-0.01 mmol/l (P < 0.05)
and -0.002+/- 0.01 mmol/l (NS) respectively. Phosphate removal was hig
her in 1.25 mM dialysate-Ca-treated patients (40.4+/-1.75 mmol/session
versus 34+/-1.3 mmol/session respectively, P < 0.015). The use of 1.2
5 mM dialysate Ca did not result in a change in serum parathormone, wh
ile the use of 1.5 mM resulted in a decrease of 43+/-15% (P < 0.02) in
patients with marked hyperparathyroidism. Conclusions. Our data remin
d us of the difficulty in assessing Ca balances and identifies the pho
sphate content as one of the factors influencing the amount of ionized
Ca in the dialysate. Although the long-term parathormone increase we
observed using 1.25 mM dialysate Ca may well not be explained only by
the acute intradialytic modifications, the negative Ca balance identif
ied here (which was missed with the analysis of ionized Ca alone), and
the lack of parathormone inhibition may participate in the relapse of
hyperparathyroidism.